共 115 条
[1]
Baena-Díez JM(2020)Standards of medical care in diabetes-2020 abridged for primary care providers Clin Diabetes 38 10-38
[2]
Peñafiel J(2016)Risk of cause-specific death in individuals with diabetes: a competing risks analysis Diabetes Care 39 1987-1995
[3]
Subirana I(2002)Control of post-prandial hyperglycemia—an essential part of good diabetes treatment and prevention of cardiovascular complications Nutr Metab Cardiovasc Dis 12 98-107
[4]
Hanefeld M(2010)Severe hypoglycemia and risks of vascular events and death New Engl J Med 363 1410-1418
[5]
Temelkova-Kurktschiev T(2004)Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up Eur J Cardiovasc Prev Rehabil 11 135-143
[6]
Zoungas S(2011)Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study Diabetes Care 34 2237-2243
[7]
Patel A(2020)Pharmacologic approaches to glycemic treatment: standards of medical care in Diabetes-2020 Diabetes Care 43 S98-S110
[8]
Chalmers J(2014)GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other? Int J Clin Pract 68 557-567
[9]
Fisman EZ(2010)Type 2 diabetes comorbidities and treatment challenges: rationale for DPP-4 inhibitors Postgrad Med 122 71-80
[10]
Motro M(2016)SGLT2 inhibitors: benefit/risk balance Curr Diabetes Rep 16 92-366